101 related articles for article (PubMed ID: 7865236)
21. [Diagnosis of recurrences of head and neck carcinoma with the tumor marker SSC-antigen].
Arlt A; Luckhaupt H; Hildmann H
Laryngorhinootologie; 2000 Apr; 79(4):207-12. PubMed ID: 10838684
[TBL] [Abstract][Full Text] [Related]
22. Expression of the double-stranded RNA-dependent protein kinase (p68) in squamous cell carcinoma of the head and neck region.
Haines GK; Becker S; Ghadge G; Kies M; Pelzer H; Radosevich JA
Arch Otolaryngol Head Neck Surg; 1993 Oct; 119(10):1142-7. PubMed ID: 8104427
[TBL] [Abstract][Full Text] [Related]
23. Squamous cell carcinoma antigen in serum for monitoring of head and neck and uterine cervical squamous cell carcinomas after radiotherapy.
Shirato H; Ichimura W; Wakushima H; Nishioka T; Suzuki K
Acta Oncol; 1993; 32(6):663-6. PubMed ID: 8260185
[TBL] [Abstract][Full Text] [Related]
24. [Telomerase activity in human head and neck squamous cell carcinoma and adjacent tissues].
Liu JF; Tao ZZ; Yang Q; Xiao BK; Zhan HZ
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2000 Jun; 14(6):246-7. PubMed ID: 12541527
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of TATI and CYFRA 21-1 in patients with head and neck squamous cell carcinoma.
Goumas PD; Mastronikolis NS; Mastorakou AN; Vassilakos PJ; Nikiforidis GC
ORL J Otorhinolaryngol Relat Spec; 1997; 59(2):106-14. PubMed ID: 9166881
[TBL] [Abstract][Full Text] [Related]
26. Elevated arginine vasopressin levels in squamous cell cancer of the head and neck.
Talmi YP; Wolf GT; Hoffman HT; Krause CJ
Laryngoscope; 1996 Mar; 106(3 Pt 1):317-21. PubMed ID: 8614196
[TBL] [Abstract][Full Text] [Related]
27. Topoisomerase I activity in squamous cell carcinoma of the head and neck.
Masin JS; Berger SJ; Setrakian S; Stepnick DW; Berger NA
Laryngoscope; 1995 Nov; 105(11):1191-6. PubMed ID: 7475874
[TBL] [Abstract][Full Text] [Related]
28. [Heat-stable alkaline phosphatase (HSAP) and fetal maturity].
Bognár VZ; Bognár E
Zentralbl Gynakol; 1975; 97(5):271-5. PubMed ID: 1217256
[TBL] [Abstract][Full Text] [Related]
29. Circulating 92-kilodalton matrix metalloproteinase (MMP-9) activity is enhanced in the euglobulin plasma fraction of head and neck squamous cell carcinoma.
Mannello F
Cancer; 2003 Jan; 97(1):201-3; author reply 203-4. PubMed ID: 12491521
[No Abstract] [Full Text] [Related]
30. Increased APN/CD13 and acid aminopeptidase activities in head and neck squamous cell carcinoma.
Pérez I; Varona A; Blanco L; Gil J; Santaolalla F; Zabala A; Ibarguen AM; Irazusta J; Larrinaga G
Head Neck; 2009 Oct; 31(10):1335-40. PubMed ID: 19373777
[TBL] [Abstract][Full Text] [Related]
31. The clinical value of serum squamous cell carcinoma antigens 1 and 2 in head and neck squamous cell carcinoma.
Yasumatsu R; Nakano T; Hashimoto K; Kogo R; Wakasaki T; Nakagawa T
Auris Nasus Larynx; 2019 Feb; 46(1):135-140. PubMed ID: 30078551
[TBL] [Abstract][Full Text] [Related]
32. Circulating microRNA-21 (MIR-21) and phosphatase and tensin homolog (PTEN) are promising novel biomarkers for detection of oral squamous cell carcinoma.
Ren W; Qiang C; Gao L; Li SM; Zhang LM; Wang XL; Dong JW; Chen C; Liu CY; Zhi KQ
Biomarkers; 2014 Nov; 19(7):590-6. PubMed ID: 25174622
[TBL] [Abstract][Full Text] [Related]
33. Analysis of preoperative serum levels of MMP1, -2, and -9 in patients with site-specific head and neck squamous cell cancer.
Kalfert D; Ludvikova M; Topolcan O; Windrichova J; Malirova E; Pesta M; Celakovsky P
Anticancer Res; 2014 Dec; 34(12):7431-41. PubMed ID: 25503184
[TBL] [Abstract][Full Text] [Related]
34. Cancer stem cell related markers of radioresistance in head and neck squamous cell carcinoma.
Kurth I; Hein L; Mäbert K; Peitzsch C; Koi L; Cojoc M; Kunz-Schughart L; Baumann M; Dubrovska A
Oncotarget; 2015 Oct; 6(33):34494-509. PubMed ID: 26460734
[TBL] [Abstract][Full Text] [Related]
35. Serum proteinase activities in head and neck squamous cell carcinoma patients.
Bongers V; Konings CH; Grijpma AM; Steen I; Braakhuis BJ; Snow GB
Anticancer Res; 1995; 15(6B):2763-6. PubMed ID: 8669860
[TBL] [Abstract][Full Text] [Related]
36. Dysregulated cholinergic network as a novel biomarker of poor prognostic in patients with head and neck squamous cell carcinoma.
Castillo-González AC; Nieto-Cerón S; Pelegrín-Hernández JP; Montenegro MF; Noguera JA; López-Moreno MF; Rodríguez-López JN; Vidal CJ; Hellín-Meseguer D; Cabezas-Herrera J
BMC Cancer; 2015 May; 15():385. PubMed ID: 25956553
[TBL] [Abstract][Full Text] [Related]
37. Monitoring a 'metabolic shift' after surgical resection of oral squamous cell carcinomas by serum lactate dehydrogenase.
Grimm M; Krimmel M; Hoefert S; Kraut W; Calgéer B; Biegner T; Teriete P; Munz A; Reinert S
J Oral Pathol Med; 2016 May; 45(5):346-55. PubMed ID: 26403591
[TBL] [Abstract][Full Text] [Related]
38. Neutrophil-to-lymphocyte ratio: Prognostic indicator for head and neck squamous cell carcinoma.
Rosculet N; Zhou XC; Ha P; Tang M; Levine MA; Neuner G; Califano J
Head Neck; 2017 Apr; 39(4):662-667. PubMed ID: 28075517
[TBL] [Abstract][Full Text] [Related]
39. Amplification of the 3q26.3 locus is associated with progression to invasive cancer and is a negative prognostic factor in head and neck squamous cell carcinomas.
Singh B; Stoffel A; Gogineni S; Poluri A; Pfister DG; Shaha AR; Pathak A; Bosl G; Cordon-Cardo C; Shah JP; Rao PH
Am J Pathol; 2002 Aug; 161(2):365-71. PubMed ID: 12163360
[TBL] [Abstract][Full Text] [Related]
40. Measurement of folylpolyglutamate synthetase activity in head and neck squamous carcinoma cell lines and clinical samples using a new rapid separation procedure.
Jansen G; Schornagel JH; Kathmann I; Westerhof GR; Hordijk GJ; van der Laan BF
Oncol Res; 1992; 4(7):299-305. PubMed ID: 1450491
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
